Wealthcare Advisory Partners LLC Bluebird Bio, Inc. Transaction History

Wealthcare Advisory Partners LLC

  • $3.43 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
BUY
$0.85 - $1.26 $15,122 - $22,416
17,791 New
17,791 $17,000
Q2 2020

Jul 29, 2020
SELL
$27.12 - $45.97 $5,424 - $9,194
-200 Closed
0 $0
Q1 2020

Apr 29, 2020
BUY
$26.16 - $63.5 $5,232 - $12,700
200 New
200 $9,000
Q2 2018

Aug 14, 2018
SELL
$99.64 - $127.59 $99,640 - $127,590
-1,000 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$105.8 - $150.94 $105,800 - $150,940
1,000 New
1,000 $171,000

Others Institutions Holding BLUE

# of Institutions
151
Shares Held
63.4M
Call Options Held
264K
Put Options Held
428K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $27M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Wealthcare Advisory Partners LLC Portfolio

Follow Wealthcare Advisory Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email